Infantile haemangioma (IH) are vascular tumours with a unique growth dynamic, mostly
absent at birth, growth in the first months followed by involution over several years, often …

Infantile haemangioma (IH) is the most frequent tumour of infancy. Although it is benign and
self-limiting, severe complications can arise due to localisation and fast tumour growth. Also …

Objective To assess the safety and efficacy of systemic propranolol for the treatment of
complicated infantile haemangiomas. Design Retrospective review of case notes of …

Abstract With a prevalence of 2.6–4.5%, infantile haemangiomas (IH) represent the most
common tumour of infancy. While the majority of IH does not require therapy and regresses …

Among benign vascular tumors of infancy, hemangiomas are the commonest, affecting
approximately 5–10% of one-year-old children. They are derived from a benign proliferation …

Infantile haemangiomas are the most common benign tumour of infancy. However the
majority are self-resolving and only a small minority of cases require treatment, with various …

Aims Propranolol, now the preferred treatment for problematic proliferating infantile
haemangioma (IH), at an empirical cardiovascular dosage of 2–3 mg/kg/day is associated …

Methods A retrospective chart review was performed on patients with infantile
haemangiomas treated with oral propranolol at the Royal Belfast Hospital for Sick Children …

METHODS: This single-arm, open-label, phase 3 study was conducted in patients aged 35
to 150 days with high-risk IH in 10 hospitals between 2015 and 2017. The study comprised a …

Objective Hemangiomas are the most common benign vascular tumors of infancy. Although
most infantile hemangiomas (IHs) have the ability to involute spontaneously after initial …